Skip to content

Author

M. El-Tanani

We have 5 of 249 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

From Neonatal History to Adult Cardiovascular Risk: Preterm Birth as a Lifelong Risk Enhancer

Background: Preterm birth is increasingly recognized as an early-life exposure with potential cardiovascular consequences across the lifespan. Although improved neonatal care has increased survival among individuals born very and extremely preterm, birth history remains rarely incorporated into cardiovascular risk asse...

M. Patni, Malek Nasrallah, D. J. Al Tarawneh et al. · 0 citations
Review Open access Jan 2026

Microbiome‐Driven Mechanisms in Breast Cancer: Emerging Evidence From Gut Microbial Signatures to Therapeutic Response

Breast cancer remains the most frequently diagnosed malignancy among women worldwide, and increasing evidence indicates that the gut microbiome plays a significant role in tumor initiation, progression, and therapeutic response. Microbial dysbiosis and altered metabolite production have been associated with systemic in...

A. Wali, S. Talath, I. Rangraze et al. · 0 citations
Review Open access Sep 2026

Bioinspired and Biomimetic Nanocarriers: Advances in Exosomes and Cell-Membrane-Coated Systems for Therapeutic Applications

Abstract The translation of nanomedicine from bench to bedside has been thwarted by the limitations of conventional synthetic nanoparticles including rapid mononuclear phagocyte system (MPS) clearance, lack of target specificity, immunogenicity and poor intracellular delivery. To overcome these limitations, bioinspired...

M. El-Tanani, S. A. Rabbani, A. Wali et al. · 0 citations
Review Open access Sep 2026

Pathological Complete Response to Nab-Paclitaxel–Containing Neoadjuvant Regimens in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

Within nab-paclitaxel-containing neoadjuvant backbones, checkpoint-inhibitor addition was associated with higher pCR in randomized comparative evidence, and should not be interpreted as a cross-regimen comparison because of clinical and methodological heterogeneity.

R. A. Salama, M. El-Tanani, S. A. Rabbani et al. · 0 citations
#explainable ai Review Open access Sep 2026

From surveillance to intelligence: a scoping review of machine learning for antimicrobial resistance surveillance intelligence across One Health

A One Health AMR Surveillance Intelligence Framework is proposed to organise this shift from data generation toward actionable, adaptive surveillance intelligence, and the evidence demonstrates technical feasibility far more convincingly than operational readiness.

S. A. Rabbani, M. El-Tanani, I. Matalka et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.